Compile Data Set for Download or QSAR

Found 50 hits Enz. Inhib. hit(s) with all data for entry = 50009907   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089055 (CHEMBL273811 | N*2*-(4-Ethanesulfonylmethyl-phenyl...) Show SMILES CCS(=O)(=O)Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 Show InChI InChI=1S/C23H22N4O2S/c1-2-30(28,29)16-17-12-14-19(15-13-17)25-23-26-21-11-7-6-10-20(21)22(27-23)24-18-8-4-3-5-9-18/h3-15H,2,16H2,1H3,(H2,24,25,26,27)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	0.600	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089048 (CHEMBL18163 | N,N-Dimethyl-C-[4-(4-phenylamino-qui...) Show SMILES CN(C)S(=O)(=O)Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 Show InChI InChI=1S/C23H23N5O2S/c1-28(2)31(29,30)16-17-12-14-19(15-13-17)25-23-26-21-11-7-6-10-20(21)22(27-23)24-18-8-4-3-5-9-18/h3-15H,16H2,1-2H3,(H2,24,25,26,27)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	0.900	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Rat 6B)	BDBM50089038 (CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...) Show SMILES Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 |wU:6.5,wD:9.9,(2.92,.42,;2.94,-1.13,;4.28,-1.89,;4.29,-3.44,;5.63,-4.22,;6.96,-3.45,;8.29,-4.21,;9.63,-3.44,;10.96,-4.22,;10.95,-5.76,;12.28,-6.54,;13.77,-6.13,;14.86,-7.21,;13.98,-8.47,;15.7,-5.91,;16.12,-8.05,;17.24,-7,;18.73,-7.45,;19.09,-8.94,;17.97,-9.99,;18.33,-11.48,;17.22,-12.56,;15.73,-12.11,;15.38,-10.62,;16.49,-9.56,;9.62,-6.51,;8.29,-5.75,;2.95,-4.23,;1.61,-3.45,;.26,-4.23,;-1.07,-3.46,;-1.07,-1.9,;.26,-1.13,;1.61,-1.9,)| Show InChI InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)/t18-,19-	UniProtKB/SwissProt GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for rat Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089069 (CHEMBL17632 | N-[4-(4-Phenylamino-quinazolin-2-yla...) Show SMILES CS(=O)(=O)NC[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ccccc2n1 |wU:9.12,wD:6.5,(17,-10.36,;16.58,-8.88,;18,-9.04,;15.26,-9.64,;16.58,-7.34,;15.26,-6.57,;13.94,-7.34,;12.59,-6.57,;11.24,-7.34,;11.27,-8.89,;12.61,-9.64,;13.94,-8.88,;9.94,-9.67,;8.6,-8.89,;8.6,-7.34,;7.25,-6.58,;7.25,-5.05,;8.57,-4.26,;8.55,-2.74,;9.87,-1.96,;11.22,-2.72,;11.24,-4.26,;9.9,-5.04,;5.93,-7.36,;4.6,-6.59,;3.26,-7.36,;3.26,-8.9,;4.6,-9.68,;5.93,-8.9,;7.27,-9.67,)| Show InChI InChI=1S/C22H27N5O2S/c1-30(28,29)23-15-16-11-13-18(14-12-16)25-22-26-20-10-6-5-9-19(20)21(27-22)24-17-7-3-2-4-8-17/h2-10,16,18,23H,11-15H2,1H3,(H2,24,25,26,27)/t16-,18-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089060 (CHEMBL273597 | Naphthalene-1-sulfonic acid [4-(4-a...) Show SMILES Nc1nc(N[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 |wU:5.4,wD:8.8,(4.65,-3.89,;4.65,-5.44,;6,-6.2,;6,-7.77,;7.33,-8.54,;8.68,-7.77,;8.66,-6.23,;10.01,-5.46,;11.34,-6.23,;12.67,-5.48,;14,-6.25,;15.33,-7.02,;15.31,-5.48,;15.31,-8.56,;16.87,-7.02,;17.2,-5.51,;18.69,-5.07,;19.81,-6.11,;19.46,-7.61,;20.6,-8.65,;20.25,-10.15,;18.78,-10.61,;17.66,-9.56,;17.99,-8.05,;11.34,-7.77,;10.01,-8.54,;4.67,-8.54,;3.32,-7.77,;1.97,-8.56,;.64,-7.77,;.64,-6.23,;1.97,-5.46,;3.32,-6.23,)| Show InChI InChI=1S/C25H27N5O2S/c26-24-21-9-3-4-10-22(21)29-25(30-24)28-19-14-12-17(13-15-19)16-27-33(31,32)23-11-5-7-18-6-1-2-8-20(18)23/h1-11,17,19,27H,12-16H2,(H3,26,28,29,30)/t17-,19-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	2.70	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089038 (CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...) Show SMILES Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 |wU:6.5,wD:9.9,(2.92,.42,;2.94,-1.13,;4.28,-1.89,;4.29,-3.44,;5.63,-4.22,;6.96,-3.45,;8.29,-4.21,;9.63,-3.44,;10.96,-4.22,;10.95,-5.76,;12.28,-6.54,;13.77,-6.13,;14.86,-7.21,;13.98,-8.47,;15.7,-5.91,;16.12,-8.05,;17.24,-7,;18.73,-7.45,;19.09,-8.94,;17.97,-9.99,;18.33,-11.48,;17.22,-12.56,;15.73,-12.11,;15.38,-10.62,;16.49,-9.56,;9.62,-6.51,;8.29,-5.75,;2.95,-4.23,;1.61,-3.45,;.26,-4.23,;-1.07,-3.46,;-1.07,-1.9,;.26,-1.13,;1.61,-1.9,)| Show InChI InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)/t18-,19-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	2.90	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089038 (CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...) Show SMILES Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 |wU:6.5,wD:9.9,(2.92,.42,;2.94,-1.13,;4.28,-1.89,;4.29,-3.44,;5.63,-4.22,;6.96,-3.45,;8.29,-4.21,;9.63,-3.44,;10.96,-4.22,;10.95,-5.76,;12.28,-6.54,;13.77,-6.13,;14.86,-7.21,;13.98,-8.47,;15.7,-5.91,;16.12,-8.05,;17.24,-7,;18.73,-7.45,;19.09,-8.94,;17.97,-9.99,;18.33,-11.48,;17.22,-12.56,;15.73,-12.11,;15.38,-10.62,;16.49,-9.56,;9.62,-6.51,;8.29,-5.75,;2.95,-4.23,;1.61,-3.45,;.26,-4.23,;-1.07,-3.46,;-1.07,-1.9,;.26,-1.13,;1.61,-1.9,)| Show InChI InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)/t18-,19-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	2.90	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for human Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089036 (CHEMBL278881 | Naphthalene-1-sulfonic acid {4-[2-(...) Show SMILES Nc1nc(NCC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 |wU:7.6,wD:10.10,(3.44,-3.9,;3.45,-5.44,;4.79,-6.21,;4.81,-7.77,;6.14,-8.54,;7.47,-7.77,;8.56,-8.87,;9.89,-8.1,;9.89,-6.56,;11.23,-5.79,;12.56,-6.56,;13.91,-5.79,;15.22,-6.58,;16.55,-7.35,;16.54,-5.81,;16.54,-8.89,;18.08,-7.35,;18.43,-5.86,;19.9,-5.4,;21.03,-6.44,;20.7,-7.94,;21.82,-8.98,;21.49,-10.48,;20,-10.94,;18.88,-9.89,;19.23,-8.4,;12.55,-8.1,;11.22,-8.87,;3.46,-8.55,;2.12,-7.77,;.77,-8.56,;-.56,-7.78,;-.56,-6.23,;.77,-5.46,;2.12,-6.23,)| Show InChI InChI=1S/C27H31N5O2S/c28-26-23-9-3-4-10-24(23)31-27(32-26)29-17-16-19-12-14-20(15-13-19)18-30-35(33,34)25-11-5-7-21-6-1-2-8-22(21)25/h1-11,19-20,30H,12-18H2,(H3,28,29,31,32)/t19-,20-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2.90	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089070 (4-Methyl-N-[4-(4-phenylamino-quinazolin-2-ylamino)...) Show SMILES Cc1ccc(cc1)S(=O)(=O)NC[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ccccc2n1 |wU:15.19,wD:12.12,(17.79,-13.14,;17.4,-11.66,;18.48,-10.56,;18.07,-9.09,;16.61,-8.7,;15.52,-9.79,;15.91,-11.26,;16.21,-7.22,;14.86,-7.98,;17.62,-7.38,;16.21,-5.68,;14.86,-4.91,;13.54,-5.68,;12.19,-4.91,;10.86,-5.68,;10.87,-7.23,;12.21,-7.98,;13.54,-7.22,;9.54,-8.01,;8.21,-7.23,;8.19,-5.68,;6.86,-4.91,;6.84,-3.38,;8.17,-2.59,;8.16,-1.07,;9.49,-.29,;10.83,-1.05,;10.84,-2.59,;9.51,-3.37,;5.53,-5.7,;4.19,-4.93,;2.86,-5.7,;2.86,-7.24,;4.19,-8.02,;5.53,-7.24,;6.87,-8.01,)| Show InChI InChI=1S/C28H31N5O2S/c1-20-11-17-24(18-12-20)36(34,35)29-19-21-13-15-23(16-14-21)31-28-32-26-10-6-5-9-25(26)27(33-28)30-22-7-3-2-4-8-22/h2-12,17-18,21,23,29H,13-16,19H2,1H3,(H2,30,31,32,33)/t21-,23-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089065 (CHEMBL279408 | N*2*-(4-Diethylamino-phenyl)-N*4*-p...) Show SMILES CCN(CC)c1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 Show InChI InChI=1S/C24H25N5/c1-3-29(4-2)20-16-14-19(15-17-20)26-24-27-22-13-9-8-12-21(22)23(28-24)25-18-10-6-5-7-11-18/h5-17H,3-4H2,1-2H3,(H2,25,26,27,28)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089063 (Acetic acid 4-(4-phenylamino-quinazolin-2-ylamino)...) Show SMILES CC(=O)O[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ccccc2n1 |wU:7.10,wD:4.3,(16.66,-8.87,;16.66,-7.34,;17.99,-6.57,;15.34,-6.58,;13.99,-7.36,;12.66,-6.58,;11.31,-7.36,;11.34,-8.91,;12.66,-9.66,;13.99,-8.89,;9.99,-9.68,;8.66,-8.91,;8.66,-7.36,;7.31,-6.59,;7.31,-5.06,;8.64,-4.26,;8.61,-2.74,;9.94,-1.96,;11.29,-2.72,;11.29,-4.26,;9.96,-5.05,;5.99,-7.37,;4.64,-6.61,;3.31,-7.37,;3.31,-8.92,;4.64,-9.7,;5.99,-8.92,;7.34,-9.68,)| Show InChI InChI=1S/C22H24N4O2/c1-15(27)28-18-13-11-17(12-14-18)24-22-25-20-10-6-5-9-19(20)21(26-22)23-16-7-3-2-4-8-16/h2-10,17-18H,11-14H2,1H3,(H2,23,24,25,26)/t17-,18-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	6	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089066 (CHEMBL276768 | Naphthalene-1-sulfonic acid (4-{[(4...) Show SMILES CN(C[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3ccccc23)CC1)c1nc(N)c2ccccc2n1 |wU:3.2,wD:6.6,(3.13,-4.29,;3.13,-2.75,;4.46,-1.99,;5.79,-2.75,;7.14,-1.98,;8.47,-2.76,;8.45,-4.3,;9.78,-5.07,;11.27,-4.67,;12.6,-5.44,;12.58,-6.98,;12.58,-3.9,;14.13,-5.44,;14.47,-3.94,;15.95,-3.48,;17.08,-4.53,;16.73,-6.02,;17.86,-7.07,;17.52,-8.57,;16.05,-9.03,;14.93,-7.98,;15.26,-6.48,;7.12,-5.06,;5.79,-4.29,;1.78,-1.98,;1.78,-.43,;.43,.34,;.43,1.88,;-.9,-.44,;-2.24,.33,;-3.58,-.44,;-3.58,-1.99,;-2.24,-2.78,;-.9,-1.99,;.45,-2.76,)| Show InChI InChI=1S/C27H31N5O2S/c1-32(27-30-24-11-5-4-10-23(24)26(28)31-27)18-20-15-13-19(14-16-20)17-29-35(33,34)25-12-6-8-21-7-2-3-9-22(21)25/h2-12,19-20,29H,13-18H2,1H3,(H2,28,30,31)/t19-,20-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089050 (CHEMBL16936 | N*2*-(4-Cyclohexyl-phenyl)-N*4*-phen...) Show SMILES C1CCC(CC1)c1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 Show InChI InChI=1S/C26H26N4/c1-3-9-19(10-4-1)20-15-17-22(18-16-20)28-26-29-24-14-8-7-13-23(24)25(30-26)27-21-11-5-2-6-12-21/h2,5-8,11-19H,1,3-4,9-10H2,(H2,27,28,29,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089058 (CHEMBL276551 | Naphthalene-1-sulfonic acid [6-(4-a...) Show SMILES Nc1nc(NCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 Show InChI InChI=1S/C24H27N5O2S/c25-23-20-13-5-6-14-21(20)28-24(29-23)26-16-7-1-2-8-17-27-32(30,31)22-15-9-11-18-10-3-4-12-19(18)22/h3-6,9-15,27H,1-2,7-8,16-17H2,(H3,25,26,28,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	28	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089054 (CHEMBL17352 | N*2*-(4-Methoxy-phenyl)-N*4*-phenyl-...) Show SMILES COc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 Show InChI InChI=1S/C21H18N4O/c1-26-17-13-11-16(12-14-17)23-21-24-19-10-6-5-9-18(19)20(25-21)22-15-7-3-2-4-8-15/h2-14H,1H3,(H2,22,23,24,25)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	33	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089044 (CHEMBL17686 | [4-(4-Phenylamino-quinazolin-2-ylami...) Show SMILES CCOP(=O)(Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1)OCC Show InChI InChI=1S/C25H27N4O3P/c1-3-31-33(30,32-4-2)18-19-14-16-21(17-15-19)27-25-28-23-13-9-8-12-22(23)24(29-25)26-20-10-6-5-7-11-20/h5-17H,3-4,18H2,1-2H3,(H2,26,27,28,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	33	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089033 (CHEMBL418359 | Naphthalene-1-sulfonic acid {3-[(4-...) Show SMILES Nc1nc(NCC2CCCC(CNS(=O)(=O)c3cccc4ccccc34)C2)nc2ccccc12 Show InChI InChI=1S/C26H29N5O2S/c27-25-22-12-3-4-13-23(22)30-26(31-25)28-16-18-7-5-8-19(15-18)17-29-34(32,33)24-14-6-10-20-9-1-2-11-21(20)24/h1-4,6,9-14,18-19,29H,5,7-8,15-17H2,(H3,27,28,30,31)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	38	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089045 (CHEMBL17196 | Naphthalene-1-sulfonic acid [7-(4-am...) Show SMILES Nc1nc(NCCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 Show InChI InChI=1S/C25H29N5O2S/c26-24-21-14-6-7-15-22(21)29-25(30-24)27-17-8-2-1-3-9-18-28-33(31,32)23-16-10-12-19-11-4-5-13-20(19)23/h4-7,10-16,28H,1-3,8-9,17-18H2,(H3,26,27,29,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	44	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089037 (CHEMBL17701 | Naphthalene-1-sulfonic acid [8-(4-am...) Show SMILES Nc1nc(NCCCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 Show InChI InChI=1S/C26H31N5O2S/c27-25-22-15-7-8-16-23(22)30-26(31-25)28-18-9-3-1-2-4-10-19-29-34(32,33)24-17-11-13-20-12-5-6-14-21(20)24/h5-8,11-17,29H,1-4,9-10,18-19H2,(H3,27,28,30,31)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	46	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089046 (CHEMBL17022 | Naphthalene-2-sulfonic acid (4-{[(na...) Show SMILES O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3ccccc3c2)CC1)c1ccc2ccccc2c1 |wU:8.8,wD:5.4,(14.76,-4.11,;14.78,-5.65,;14.76,-7.18,;13.46,-4.87,;12.12,-5.62,;10.79,-4.85,;10.81,-3.3,;9.47,-2.51,;8.15,-3.28,;6.82,-2.49,;5.48,-3.25,;4.15,-2.49,;2.82,-3.25,;2.82,-4.79,;1.48,-5.55,;.15,-4.78,;-1.18,-5.55,;-2.5,-4.78,;-2.5,-3.23,;-1.18,-2.47,;.15,-3.23,;1.48,-2.47,;8.13,-4.83,;9.45,-5.6,;16.13,-4.9,;16.13,-3.36,;17.48,-2.61,;18.8,-3.4,;20.15,-2.65,;21.47,-3.44,;21.45,-4.99,;20.09,-5.74,;18.78,-4.94,;17.46,-5.68,)| Show InChI InChI=1S/C29H32N2O2S/c32-34(33,29-16-15-26-6-2-4-8-28(26)18-29)31-21-23-11-9-22(10-12-23)19-30-20-24-13-14-25-5-1-3-7-27(25)17-24/h1-8,13-18,22-23,30-31H,9-12,19-21H2/t22-,23-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	47	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089047 (CHEMBL17914 | N*2*-Cyclohexyl-N*4*-phenyl-quinazol...) Show SMILES C1CCC(CC1)Nc1nc(Nc2ccccc2)c2ccccc2n1 Show InChI InChI=1S/C20H22N4/c1-3-9-15(10-4-1)21-19-17-13-7-8-14-18(17)23-20(24-19)22-16-11-5-2-6-12-16/h1,3-4,7-10,13-14,16H,2,5-6,11-12H2,(H2,21,22,23,24)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	50	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089043 (CHEMBL17417 | N*2*-{2-[1-(Naphthalene-1-sulfonyl)-...) Show SMILES Nc1nc(NCCC2CCN(CC2)S(=O)(=O)c2cccc3ccccc23)nc2ccccc12 Show InChI InChI=1S/C25H27N5O2S/c26-24-21-9-3-4-10-22(21)28-25(29-24)27-15-12-18-13-16-30(17-14-18)33(31,32)23-11-5-7-19-6-1-2-8-20(19)23/h1-11,18H,12-17H2,(H3,26,27,28,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	51	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089032 (CHEMBL17395 | N-{4-[4-(4-Chloro-phenylamino)-quina...) Show SMILES CN(C[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(Cl)cc2)c2ccccc2n1)C(C)=O |wU:6.9,wD:3.2,(15.46,-3.75,;14.14,-4.52,;12.79,-3.76,;11.46,-4.52,;10.13,-3.76,;8.78,-4.54,;8.8,-6.08,;10.13,-6.84,;11.46,-6.08,;7.46,-6.85,;6.12,-6.08,;6.11,-4.54,;4.77,-3.78,;4.76,-2.23,;6.1,-1.45,;7.43,-2.22,;8.76,-1.44,;8.75,.11,;10.09,.88,;7.4,.86,;6.08,.09,;3.44,-4.55,;2.1,-3.78,;.77,-4.55,;.77,-6.11,;2.1,-6.87,;3.44,-6.1,;4.78,-6.87,;14.14,-6.08,;15.48,-6.83,;12.8,-6.84,)| Show InChI InChI=1S/C24H28ClN5O/c1-16(31)30(2)15-17-7-11-20(12-8-17)27-24-28-22-6-4-3-5-21(22)23(29-24)26-19-13-9-18(25)10-14-19/h3-6,9-10,13-14,17,20H,7-8,11-12,15H2,1-2H3,(H2,26,27,28,29)/t17-,20-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	58	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089040 (CHEMBL17483 | N*2*,N*4*-Diphenyl-quinazoline-2,4-d...) Show SMILES N(c1ccccc1)c1nc(Nc2ccccc2)c2ccccc2n1 Show InChI InChI=1S/C20H16N4/c1-3-9-15(10-4-1)21-19-17-13-7-8-14-18(17)23-20(24-19)22-16-11-5-2-6-12-16/h1-14H,(H2,21,22,23,24)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	80	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089067 (CHEMBL17326 | N*2*-(4-Chloro-phenyl)-N*4*-phenyl-q...) Show SMILES Clc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 Show InChI InChI=1S/C20H15ClN4/c21-14-10-12-16(13-11-14)23-20-24-18-9-5-4-8-17(18)19(25-20)22-15-6-2-1-3-7-15/h1-13H,(H2,22,23,24,25)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	100	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089051 (CHEMBL17911 | Naphthalene-1-sulfonic acid {4-[(4-a...) Show SMILES CN(C[C@H]1CC[C@H](CNc2nc(N)c3ccccc3n2)CC1)S(=O)(=O)c1cccc2ccccc12 |wU:6.6,wD:3.2,(11.05,-6.14,;11.27,-4.67,;9.78,-5.07,;8.45,-4.3,;8.47,-2.76,;7.14,-1.98,;5.79,-2.75,;4.46,-1.99,;3.13,-2.75,;1.78,-1.98,;1.78,-.43,;.43,.34,;.43,1.88,;-.9,-.44,;-2.24,.33,;-3.58,-.44,;-3.58,-1.99,;-2.24,-2.78,;-.9,-1.99,;.45,-2.76,;5.79,-4.29,;7.12,-5.06,;12.6,-5.44,;12.58,-3.9,;12.58,-6.98,;14.13,-5.44,;14.47,-3.94,;15.95,-3.48,;17.08,-4.53,;16.73,-6.02,;17.86,-7.07,;17.52,-8.57,;16.05,-9.03,;14.93,-7.98,;15.26,-6.48,)| Show InChI InChI=1S/C27H31N5O2S/c1-32(35(33,34)25-12-6-8-21-7-2-3-9-22(21)25)18-20-15-13-19(14-16-20)17-29-27-30-24-11-5-4-10-23(24)26(28)31-27/h2-12,19-20H,13-18H2,1H3,(H3,28,29,30,31)/t19-,20-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	110	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089062 (1'-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-4-cyclo...) Show SMILES COc1cc2nc(nc(N)c2cc1OC)N1CCC(CC1)N1C(=O)CC(CC1=O)C1CCCCC1 Show InChI InChI=1S/C26H35N5O4/c1-34-21-14-19-20(15-22(21)35-2)28-26(29-25(19)27)30-10-8-18(9-11-30)31-23(32)12-17(13-24(31)33)16-6-4-3-5-7-16/h14-18H,3-13H2,1-2H3,(H2,27,28,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	160	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089057 (CHEMBL429053 | N*4*-Phenyl-N*2*-p-tolyl-quinazolin...) Show SMILES Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 Show InChI InChI=1S/C21H18N4/c1-15-11-13-17(14-12-15)23-21-24-19-10-6-5-9-18(19)20(25-21)22-16-7-3-2-4-8-16/h2-14H,1H3,(H2,22,23,24,25)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	200	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089061 (CHEMBL17450 | N*2*-(3-Dibutylamino-propyl)-N*4*-(3...) Show SMILES CCCCN(CCCC)CCCNc1nc(Nc2cccc(c2)C(F)(F)F)c2ccccc2n1 Show InChI InChI=1S/C26H34F3N5/c1-3-5-16-34(17-6-4-2)18-10-15-30-25-32-23-14-8-7-13-22(23)24(33-25)31-21-12-9-11-20(19-21)26(27,28)29/h7-9,11-14,19H,3-6,10,15-18H2,1-2H3,(H2,30,31,32,33)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	210	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089031 (CHEMBL17427 | N-{4-[4-(4-Chloro-phenylamino)-quina...) Show SMILES CN(C[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(Cl)cc2)c2ccccc2n1)C(=O)c1ccccc1 |wU:6.9,wD:3.2,(18.77,-3.23,;17.43,-4.02,;16.1,-3.23,;14.77,-4.02,;13.43,-3.23,;12.1,-4.02,;12.1,-5.56,;13.44,-6.32,;14.77,-5.56,;10.78,-6.34,;9.43,-5.57,;9.43,-4.02,;8.09,-3.26,;8.09,-1.73,;9.41,-.94,;10.73,-1.72,;12.07,-.94,;12.06,.6,;13.4,1.39,;10.71,1.36,;9.39,.58,;6.76,-4.04,;5.43,-3.27,;4.09,-4.04,;4.09,-5.58,;5.43,-6.36,;6.76,-5.58,;8.11,-6.35,;17.43,-5.56,;16.1,-6.32,;18.77,-6.31,;20.09,-5.53,;21.43,-6.3,;21.44,-7.85,;20.1,-8.62,;18.77,-7.85,)| Show InChI InChI=1S/C29H30ClN5O/c1-35(28(36)21-7-3-2-4-8-21)19-20-11-15-24(16-12-20)32-29-33-26-10-6-5-9-25(26)27(34-29)31-23-17-13-22(30)14-18-23/h2-10,13-14,17-18,20,24H,11-12,15-16,19H2,1H3,(H2,31,32,33,34)/t20-,24-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	250	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089034 (CHEMBL17247 | N*2*-(3,4-Dichloro-phenyl)-N*4*-phen...) Show SMILES Clc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1Cl Show InChI InChI=1S/C20H14Cl2N4/c21-16-11-10-14(12-17(16)22)24-20-25-18-9-5-4-8-15(18)19(26-20)23-13-6-2-1-3-7-13/h1-12H,(H2,23,24,25,26)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	270	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089053 (CHEMBL278677 | Naphthalene-1-sulfonic acid 4-[(4-a...) Show SMILES Nc1nc(NCc2ccc(CNS(=O)(=O)c3cccc4ccccc34)cc2)nc2ccccc12 Show InChI InChI=1S/C26H23N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-15,29H,16-17H2,(H3,27,28,30,31)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	290	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089056 (CHEMBL279181 | N-{4-[4-(4-Chloro-phenylamino)-quin...) Show SMILES Clc1ccc(Nc2nc(N[C@H]3CC[C@H](CNC(=O)c4ccccc4)CC3)nc3ccccc23)cc1 |wU:10.9,wD:13.13,(8.69,-.68,;7.36,-1.47,;7.37,-3.01,;6.04,-3.79,;4.71,-3.02,;3.38,-3.79,;3.39,-5.33,;4.72,-6.1,;4.74,-7.64,;6.07,-8.41,;7.4,-7.64,;7.38,-6.1,;8.73,-5.32,;10.06,-6.09,;11.39,-5.32,;12.72,-6.09,;12.72,-7.63,;11.39,-8.4,;14.07,-8.38,;15.38,-7.61,;16.71,-8.38,;16.73,-9.92,;15.4,-10.69,;14.05,-9.92,;10.06,-7.63,;8.73,-8.4,;3.41,-8.41,;2.06,-7.65,;.73,-8.43,;-.6,-7.66,;-.6,-6.11,;.73,-5.34,;2.06,-6.11,;4.7,-1.49,;6.02,-.71,)| Show InChI InChI=1S/C28H28ClN5O/c29-21-12-16-22(17-13-21)31-26-24-8-4-5-9-25(24)33-28(34-26)32-23-14-10-19(11-15-23)18-30-27(35)20-6-2-1-3-7-20/h1-9,12-13,16-17,19,23H,10-11,14-15,18H2,(H,30,35)(H2,31,32,33,34)/t19-,23-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	310	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089059 (CHEMBL16965 | Naphthalene-1-sulfonic acid 3-[(4-am...) Show SMILES Nc1nc(NCc2cccc(CNS(=O)(=O)c3cccc4ccccc34)c2)nc2ccccc12 Show InChI InChI=1S/C26H23N5O2S/c27-25-22-12-3-4-13-23(22)30-26(31-25)28-16-18-7-5-8-19(15-18)17-29-34(32,33)24-14-6-10-20-9-1-2-11-21(20)24/h1-15,29H,16-17H2,(H3,27,28,30,31)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	380	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089042 (CHEMBL17398 | N-{4-[4-(4-Chloro-phenylamino)-quina...) Show SMILES CC(=O)NC[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(Cl)cc2)c2ccccc2n1 |wU:8.11,wD:5.4,(15.06,-7.1,;13.73,-6.33,;12.4,-7.1,;13.73,-4.79,;12.39,-4.02,;11.06,-4.79,;9.71,-4.02,;8.38,-4.81,;8.4,-6.35,;9.73,-7.1,;11.06,-6.33,;7.07,-7.12,;5.72,-6.35,;5.72,-4.81,;4.37,-4.04,;4.37,-2.5,;5.7,-1.73,;7.03,-2.5,;8.36,-1.71,;8.35,-.17,;9.68,.6,;7.01,.58,;5.68,-.19,;3.06,-4.81,;1.71,-4.04,;.38,-4.81,;.38,-6.37,;1.71,-7.14,;3.06,-6.35,;4.39,-7.12,)| Show InChI InChI=1S/C23H26ClN5O/c1-15(30)25-14-16-6-10-19(11-7-16)27-23-28-21-5-3-2-4-20(21)22(29-23)26-18-12-8-17(24)9-13-18/h2-5,8-9,12-13,16,19H,6-7,10-11,14H2,1H3,(H,25,30)(H2,26,27,28,29)/t16-,19-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	390	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089052 (Benzoic acid 4-(4-phenylamino-quinazolin-2-ylamino...) Show SMILES O=C(O[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ccccc2n1)c1ccccc1 |wU:6.9,wD:3.2,(17.99,-6.34,;16.66,-7.1,;15.32,-6.35,;13.99,-7.13,;12.66,-6.35,;11.31,-7.13,;11.34,-8.68,;12.66,-9.43,;13.99,-8.66,;9.99,-9.45,;8.66,-8.68,;8.66,-7.13,;7.31,-6.36,;7.31,-4.82,;8.64,-4.03,;8.62,-2.51,;9.94,-1.73,;11.29,-2.49,;11.29,-4.03,;9.96,-4.82,;5.99,-7.14,;4.64,-6.37,;3.31,-7.14,;3.31,-8.69,;4.64,-9.47,;5.99,-8.69,;7.34,-9.45,;16.66,-8.64,;17.99,-9.4,;18.01,-10.92,;16.69,-11.71,;15.34,-10.94,;15.34,-9.41,)| Show InChI InChI=1S/C27H26N4O2/c32-26(19-9-3-1-4-10-19)33-22-17-15-21(16-18-22)29-27-30-24-14-8-7-13-23(24)25(31-27)28-20-11-5-2-6-12-20/h1-14,21-22H,15-18H2,(H2,28,29,30,31)/t21-,22-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	400	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089049 (CHEMBL17454 | N*4*-(4-Chloro-phenyl)-N*2*-(4-methy...) Show SMILES CNC[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(Cl)cc2)c2ccccc2n1 |wU:6.9,wD:3.2,(15.4,-6.98,;15.4,-5.44,;14.07,-4.67,;12.72,-5.44,;11.39,-4.67,;10.06,-5.46,;10.06,-7,;11.41,-7.75,;12.72,-6.98,;8.73,-7.77,;7.4,-7.01,;7.4,-5.46,;6.05,-4.7,;6.05,-3.16,;7.38,-2.38,;8.71,-3.15,;10.04,-2.36,;10.03,-.82,;11.36,-.05,;8.69,-.05,;7.36,-.85,;4.74,-5.47,;3.39,-4.7,;2.06,-5.47,;2.06,-7.02,;3.39,-7.79,;4.74,-7.01,;6.07,-7.78,)| Show InChI InChI=1S/C22H26ClN5/c1-24-14-15-6-10-18(11-7-15)26-22-27-20-5-3-2-4-19(20)21(28-22)25-17-12-8-16(23)9-13-17/h2-5,8-9,12-13,15,18,24H,6-7,10-11,14H2,1H3,(H2,25,26,27,28)/t15-,18-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	510	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089064 (CHEMBL275845 | Naphthalene-1-sulfonic acid (4-{[(4...) Show SMILES CN(C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2cccc3ccccc23)CC1)c1nc(N)c2ccccc2n1 |wU:3.2,wD:6.6,(2.68,-4.08,;2.68,-2.54,;4.02,-1.77,;5.35,-2.53,;6.69,-1.76,;8.02,-2.54,;8,-4.08,;9.33,-4.86,;10.83,-4.45,;10.61,-5.93,;12.15,-5.22,;12.13,-6.76,;12.13,-3.68,;13.69,-5.22,;14.02,-3.71,;15.5,-3.27,;16.63,-4.31,;16.28,-5.81,;17.42,-6.85,;17.07,-8.35,;15.61,-8.81,;14.48,-7.76,;14.81,-6.26,;6.68,-4.83,;5.35,-4.06,;1.34,-1.76,;1.34,-.21,;-.02,.55,;-.02,2.1,;-1.34,-.22,;-2.68,.55,;-4.03,-.22,;-4.03,-1.78,;-2.68,-2.55,;-1.34,-1.77,;.01,-2.55,)| Show InChI InChI=1S/C28H33N5O2S/c1-32(28-30-25-12-6-5-11-24(25)27(29)31-28)18-20-14-16-21(17-15-20)19-33(2)36(34,35)26-13-7-9-22-8-3-4-10-23(22)26/h3-13,20-21H,14-19H2,1-2H3,(H2,29,30,31)/t20-,21-	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	710	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 1 (Homo sapiens (Human))	BDBM50089061 (CHEMBL17450 | N*2*-(3-Dibutylamino-propyl)-N*4*-(3...) Show SMILES CCCCN(CCCC)CCCNc1nc(Nc2cccc(c2)C(F)(F)F)c2ccccc2n1 Show InChI InChI=1S/C26H34F3N5/c1-3-5-16-34(17-6-4-2)18-10-15-30-25-32-23-14-8-7-13-22(23)24(33-25)31-21-12-9-11-20(19-21)26(27,28)29/h7-9,11-14,19H,3-6,10,15-18H2,1-2H3,(H2,30,31,32,33)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089041 (CHEMBL275610 | [1-(Naphthalene-1-sulfonyl)-piperid...) Show SMILES O=S(=O)(N1CCC(CNCc2ccc3ccccc3c2)CC1)c1cccc2ccccc12 Show InChI InChI=1S/C27H28N2O2S/c30-32(31,27-11-5-9-24-7-3-4-10-26(24)27)29-16-14-21(15-17-29)19-28-20-22-12-13-23-6-1-2-8-25(23)18-22/h1-13,18,21,28H,14-17,19-20H2	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089035 (2-[1-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piper...) Show SMILES COc1cc2nc(nc(N)c2cc1OC)N1CCC(CC1)N1Cc2ccccc2C1=O Show InChI InChI=1S/C23H25N5O3/c1-30-19-11-17-18(12-20(19)31-2)25-23(26-21(17)24)27-9-7-15(8-10-27)28-13-14-5-3-4-6-16(14)22(28)29/h3-6,11-12,15H,7-10,13H2,1-2H3,(H2,24,25,26)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.40E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 2 (Homo sapiens (Human))	BDBM50089038 (CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...) Show SMILES Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 |wU:6.5,wD:9.9,(2.92,.42,;2.94,-1.13,;4.28,-1.89,;4.29,-3.44,;5.63,-4.22,;6.96,-3.45,;8.29,-4.21,;9.63,-3.44,;10.96,-4.22,;10.95,-5.76,;12.28,-6.54,;13.77,-6.13,;14.86,-7.21,;13.98,-8.47,;15.7,-5.91,;16.12,-8.05,;17.24,-7,;18.73,-7.45,;19.09,-8.94,;17.97,-9.99,;18.33,-11.48,;17.22,-12.56,;15.73,-12.11,;15.38,-10.62,;16.49,-9.56,;9.62,-6.51,;8.29,-5.75,;2.95,-4.23,;1.61,-3.45,;.26,-4.23,;-1.07,-3.46,;-1.07,-1.9,;.26,-1.13,;1.61,-1.9,)| Show InChI InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)/t18-,19-	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.89E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for human Neuropeptide Y receptor type 2				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089039 (CHEMBL17441 | N*2*-(4-Amino-butyl)-6-phenyl-quinaz...) Show SMILES NCCCCNc1nc(N)c2cc(ccc2n1)-c1ccccc1 Show InChI InChI=1S/C18H21N5/c19-10-4-5-11-21-18-22-16-9-8-14(12-15(16)17(20)23-18)13-6-2-1-3-7-13/h1-3,6-9,12H,4-5,10-11,19H2,(H3,20,21,22,23)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	2.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50089068 (CHEMBL277551 | Naphthalene-1-sulfonic acid [(1R,2S...) Show SMILES Nc1nc(N[C@H]2CCCC[C@H]2NS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 Show InChI InChI=1S/C24H25N5O2S/c25-23-18-11-3-4-12-19(18)26-24(28-23)27-20-13-5-6-14-21(20)29-32(30,31)22-15-7-9-16-8-1-2-10-17(16)22/h1-4,7-12,15,20-21,29H,5-6,13-14H2,(H3,25,26,27,28)/t20-,21+/m0/s1	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	4.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 4 (Homo sapiens (Human))	BDBM50089038 (CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...) Show SMILES Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 |wU:6.5,wD:9.9,(2.92,.42,;2.94,-1.13,;4.28,-1.89,;4.29,-3.44,;5.63,-4.22,;6.96,-3.45,;8.29,-4.21,;9.63,-3.44,;10.96,-4.22,;10.95,-5.76,;12.28,-6.54,;13.77,-6.13,;14.86,-7.21,;13.98,-8.47,;15.7,-5.91,;16.12,-8.05,;17.24,-7,;18.73,-7.45,;19.09,-8.94,;17.97,-9.99,;18.33,-11.48,;17.22,-12.56,;15.73,-12.11,;15.38,-10.62,;16.49,-9.56,;9.62,-6.51,;8.29,-5.75,;2.95,-4.23,;1.61,-3.45,;.26,-4.23,;-1.07,-3.46,;-1.07,-1.9,;.26,-1.13,;1.61,-1.9,)| Show InChI InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)/t18-,19-	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	5.74E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for human Neuropeptide Y receptor type 4				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 1 (Homo sapiens (Human))	BDBM50089039 (CHEMBL17441 | N*2*-(4-Amino-butyl)-6-phenyl-quinaz...) Show SMILES NCCCCNc1nc(N)c2cc(ccc2n1)-c1ccccc1 Show InChI InChI=1S/C18H21N5/c19-10-4-5-11-21-18-22-16-9-8-14(12-15(16)17(20)23-18)13-6-2-1-3-7-13/h1-3,6-9,12H,4-5,10-11,19H2,(H3,20,21,22,23)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	8.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 1 (Homo sapiens (Human))	BDBM50089038 (CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...) Show SMILES Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 |wU:6.5,wD:9.9,(2.92,.42,;2.94,-1.13,;4.28,-1.89,;4.29,-3.44,;5.63,-4.22,;6.96,-3.45,;8.29,-4.21,;9.63,-3.44,;10.96,-4.22,;10.95,-5.76,;12.28,-6.54,;13.77,-6.13,;14.86,-7.21,;13.98,-8.47,;15.7,-5.91,;16.12,-8.05,;17.24,-7,;18.73,-7.45,;19.09,-8.94,;17.97,-9.99,;18.33,-11.48,;17.22,-12.56,;15.73,-12.11,;15.38,-10.62,;16.49,-9.56,;9.62,-6.51,;8.29,-5.75,;2.95,-4.23,;1.61,-3.45,;.26,-4.23,;-1.07,-3.46,;-1.07,-1.9,;.26,-1.13,;1.61,-1.9,)| Show InChI InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)/t18-,19-	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	8.37E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for human Neuropeptide Y receptor type 1				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 1 (Homo sapiens (Human))	BDBM50089062 (1'-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-4-cyclo...) Show SMILES COc1cc2nc(nc(N)c2cc1OC)N1CCC(CC1)N1C(=O)CC(CC1=O)C1CCCCC1 Show InChI InChI=1S/C26H35N5O4/c1-34-21-14-19-20(15-22(21)35-2)28-26(29-25(19)27)30-10-8-18(9-11-30)31-23(32)12-17(13-24(31)33)16-6-4-3-5-7-16/h14-18H,3-13H2,1-2H3,(H2,27,28,29)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	8.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 1 (Homo sapiens (Human))	BDBM50089046 (CHEMBL17022 | Naphthalene-2-sulfonic acid (4-{[(na...) Show SMILES O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3ccccc3c2)CC1)c1ccc2ccccc2c1 |wU:8.8,wD:5.4,(14.76,-4.11,;14.78,-5.65,;14.76,-7.18,;13.46,-4.87,;12.12,-5.62,;10.79,-4.85,;10.81,-3.3,;9.47,-2.51,;8.15,-3.28,;6.82,-2.49,;5.48,-3.25,;4.15,-2.49,;2.82,-3.25,;2.82,-4.79,;1.48,-5.55,;.15,-4.78,;-1.18,-5.55,;-2.5,-4.78,;-2.5,-3.23,;-1.18,-2.47,;.15,-3.23,;1.48,-2.47,;8.13,-4.83,;9.45,-5.6,;16.13,-4.9,;16.13,-3.36,;17.48,-2.61,;18.8,-3.4,;20.15,-2.65,;21.47,-3.44,;21.45,-4.99,;20.09,-5.74,;18.78,-4.94,;17.46,-5.68,)| Show InChI InChI=1S/C29H32N2O2S/c32-34(33,29-16-15-26-6-2-4-8-28(26)18-29)31-21-23-11-9-22(10-12-23)19-30-20-24-13-14-25-5-1-3-7-27(25)17-24/h1-8,13-18,22-23,30-31H,9-12,19-21H2/t22-,23-	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 1 (Homo sapiens (Human))	BDBM50089035 (2-[1-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piper...) Show SMILES COc1cc2nc(nc(N)c2cc1OC)N1CCC(CC1)N1Cc2ccccc2C1=O Show InChI InChI=1S/C23H25N5O3/c1-30-19-11-17-18(12-20(19)31-2)25-23(26-21(17)24)27-9-7-15(8-10-27)28-13-14-5-3-4-6-16(14)22(28)29/h3-6,11-12,15H,7-10,13H2,1-2H3,(H2,24,25,26)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	6.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Novartis Pharma AG Curated by ChEMBL					Assay Description Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1				Bioorg Med Chem Lett 10: 1175-9 (2000) BindingDB Entry DOI: 10.7270/Q2KH0MJP
					More data for this Ligand-Target Pair